Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Huntingdon Life Sciences
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
{{Short description|Contract research organisation}} {{Use dmy dates|date=August 2018}} {{Infobox company | name = Huntingdon Life Sciences | logo = File:Huntingdon-logo-for-wiki.jpg | fate = Merged into Envigo (now [[Inotiv]]) | successor = [[Inotiv]] | foundation = {{start date and age|1951}} in [[Cambridgeshire, England]] | location = [[East Millstone, New Jersey]] | area_served = Global | key_people = [[Brian Cass]], Former Managing Director | industry = [[Pharmaceutical industry]] | services = [[Contract research organization]] | revenue = $242 million | operating_income = $35 million | net_income = $10 million | assets = $171 million | equity = -$15 million | num_employees = >1,600 | footnotes = <ref name=10K>{{cite news| url=https://www.sec.gov/Archives/edgar/data/1158833/000115883309000010/form10k2008.htm | publisher=[[U.S. Securities and Exchange Commission]] | title=LIFE SCIENCES RESEARCH INC. Form 10-K for the Fiscal Year Ended December 31, 2008 | date=March 16, 2009}}</ref> }} '''Huntingdon Life Sciences''' ('''HLS''') was a [[contract research organisation]] (CRO) organized in Maryland and headquartered in [[East Millstone, New Jersey]]. It was founded in 1951 in [[Cambridgeshire, England]]. It had two laboratories in the United Kingdom and one in the United States. With over 1,600 employees, it was the largest non-clinical CRO in Europe and the third-largest non-clinical CRO in the world.<ref>{{cite news | url=https://www.outsourcing-pharma.com/Article/2014/05/07/Huntingdon-buys-Harlan-to-form-3rd-largest-preclinical-CRO |title=Huntingdon buys Harlan to form 3rd largest preclinical CRO | first=Dan | last=Stanton | work=Outsourcing Pharma | date=6 May 2014}}</ref> In September 2015, Huntingdon Life Sciences, [[Harlan (company)|Harlan Laboratories]], GFA, NDA Analytics and LSR associates merged into Envigo (now [[Inotiv]]). HLS provided [[contract research organization]] services in pre-clinical and non-clinical biological safety evaluation research. As with other major CROs operating in this business area, its major business is serving the pharmaceutical industry. However, more than a third of its business came from non-pharmaceutical sources, such as the [[crop protection]] industry which accounts for around 60% of its non-pharmaceutical business. HLS had two facilities in the UK ([[Huntingdon]], Cambridgeshire and [[Eye, Suffolk]]), one in the USA ([[East Millstone, New Jersey]]) and an office in Japan (Tokyo). The company was one of the largest participants in the [[international primate trade]] and has been criticized for its [[animal testing]] practices, most specifically [[animal testing on non-human primates]] as well as on [[beagle]]s. The [[Stop Huntingdon Animal Cruelty]] campaign was formed with the goal of shutting down the company due to [[animal rights]] violations.
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)